Q2 2021 Biosyent Inc Earnings Call Transcript
© -
Hello, and welcome to the BioSyent Q2 and First Half 2021 Results Presentation. My name is René Goehrum, and I'm the President and CEO of the company. I want to start today's presentation with a look at our sales, EBITDA and net income after tax for the quarter ended June 30, 2021.
So the quarter represented our 44th consecutive profitable quarter, dating back all the way to Q2 of 2010 when the company turned profitable. Sales were just under $7.3 million, up 53% versus a year ago, and a couple of things I would like to bring to your attention. In the year ago second quarter, we had some softness, and I would take you back to Wave 1 of COVID. In March of 2020, we had a surge in sales, both for wholesale distribution of pharmacies and the hospitals doing some stockpiling. So what we found there was exceptionally high sales in March of 2020 and then a sharp dropoff in April of 2020 and then a building back in May. And June last year is kind of business normalized, and then we proceeded to grow the business over that
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
